QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced full results for the third quarter of 2026, with net sales and adjusted diluted earnings per share (EPS) ahead of the outlook. In line with preliminary results, Q3 2026 sales rose 3% to $548 million compared with Q3 2025, also...